相关实验视频

Updated: Mar 16, 2026

Purification of Biotinylated Cell Surface Proteins from Rhipicephalus microplus Epithelial Gut Cells

Purification of Biotinylated Cell Surface Proteins from Rhipicephalus microplus Epithelial Gut Cells

Published on: July 23, 2017

纯种和杂种牛群中Rhipicephalus microplus感染的多基因控制,由GWAS揭示

M R S Simões¹, G S Campos², C C G Gomes³

¹Graduate Program in Animal Science - Federal University of Pelotas (UFPEL), Pelotas, 96010-900, RS, Brazil.

Molecular and biochemical parasitology

|March 14, 2026

概括

与其他品种和杂交品种相比,Nellore牛表现出优越的抗性. 基因组工具可以帮助选择对Rhipicephalus (Boophilus) 微积分的抗性增强的牛.

科学领域:

动物科学动物科学
遗传学是一个遗传学.
兽医昆虫学兽医昆虫学

背景情况:

牛的耐药性对于牛群的生产力和动物福利至关重要,特别是在巴西,那里Rhipicephalus (Boophilus) 微型动物普遍存在.
品种差异显著影响抗性,影响牛肉生产的竞争力.

研究的目的:

为了评估巴西里约格兰德杜苏尔 (Rio Grande do Sul) taurine,indicine和杂交牛的抗性.
评估基因组工具的潜力,以选择具有更好的抗性牛.

主要方法:

用一个重复测量混合模型来比较不同品种群的平均负荷.
进行了全基因组关联研究 (GWAS),以确定与抗性相关的基因组区域.
使用MeSH丰富分析,在已识别的基因组区域内表征候选基因.

主要成果:

尼罗尔牛的平均数量最低,这表明它们的抗性更高.
在数中观察到大量的品种群差异,安格斯和赫雷福德品种及其交叉品种显示出更高的感染水平.
感染的遗传性和重复性分别估计为0.165和0.179.
3,4,5,16和22染色体上的基因组区域与负荷的变化有关.

结论:

牛的耐性是一种多基因特征,受多个基因的影响.
基因组信息对于在纯种和杂种牛群中提高耐性选策略是有价值的.
使用基因组工具进行有针对性的选择可以提高牛对Rhipicephalus (Boophilus) 微型虫感染的抵抗力.

关键词:

基因组协会基因组协会异质化是一种异质化.畜牧业畜牧业畜牧业畜牧业一个提克提克,一个提克提克.

更多相关视频

Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization

Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

RNA Interference in Ticks

RNA Interference in Ticks

Published on: January 20, 2011

相关概念视频

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...